60 Day FRN

Evaluation of Technical Assistance and Training Approaches to Accelerate Comprehensive Cancer
Control Outcomes

Attachment 9.
Federal Register Notice

1

66004

Federal Register / Vol. 88, No. 185 / Tuesday, September 26, 2023 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondents

Form name

Physician ................................

Chronic Q fever Enhanced Surveillance Report Form—Initial
Consult.
Chronic Q fever Enhanced Surveillance Report Form—Follow-up.

Physician ................................

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2023–20759 Filed 9–25–23; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–23–23IE; Docket No. CDC–2023–
0077]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled Social and
Economic Barriers to Receiving Optimal
Services Along the Cancer Care
Continuum. This mixed methods data
collection effort will help CDC
understand the social and economic
barriers that colorectal, breast, and
cervical cancer survivors and their
caregivers face at each stage of the
cancer care continuum, from screening
through survivorship, and how these
barriers may vary by population.
DATES: CDC must receive written
comments on or before November 27,
2023.

lotter on DSK11XQN23PROD with NOTICES1

SUMMARY:

You may submit comments,
identified by Docket No. CDC–2023–
0077 by either of the following methods:

ADDRESSES:

VerDate Sep<11>2014

18:18 Sep 25, 2023

Jkt 259001

Number of
respondents

• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;

PO 00000

Frm 00059

Fmt 4703

Sfmt 4703

Number
of responses
per
respondent

Average
burden
per response
(in hours)

50

1

20/60

50

2

10/60

2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Social and Economic Barriers to
Receiving Optimal Services Along the
Cancer Care Continuum—New—
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC)
Background and Brief Description
The purpose of this project is to: (1)
examine and better understand social
and economic barriers faced by
colorectal, breast, and cervical cancer
survivors and their caregivers at each
stage of the Cancer Care Continuum
(CCC); and (2) quantify the impact of
individual and compounded barriers on
health outcomes along the CCC for
survivors. CDC will use a mixed
methods data collection approach.
First, CDC plans to pull our sample
from cancer registry data in California,
North Carolina, and Texas based on
inclusion criteria (received first cancer
diagnosis of either breast, cervical or
colorectal cancer in 2021; 18–75 years of
age at time of diagnosis; are nonHispanic Black/African American, nonHispanic White, or Hispanic; alive at the
time of data extraction/sample
selection). Then, CDC will administer a
Wave 1 (baseline) and Wave 2 (followup) survey to cancer survivors, as well
as a survey to their caregivers.
Additionally, CDC will conduct
interviews with survivors and caregivers
as well as focus groups with

E:\FR\FM\26SEN1.SGM

26SEN1

66005

Federal Register / Vol. 88, No. 185 / Tuesday, September 26, 2023 / Notices
representatives from patient/survivor
advocacy organizations. CDC will
incorporate cancer registry data into the
quantitative data analysis, and
triangulate findings from the
quantitative and qualitative data

collection efforts. Results will be used to
inform efforts aimed at increasing access
to cancer care services, reducing the
burden of cancers and closing the
disparities gap.

CDC requests OMB approval for an
estimated 1,681 annual burden hours.
There are no costs to respondents other
than their time to participate.

ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)

Total
burden
(in hours)

Form name

Wave 1 Survivor Survey Respondents.
Wave 2 Survivor Survey Respondents.
Survivor Interviewees ........................
Caregiver Survey Respondents ........
Caregiver Interviewees .....................
Patient Advocacy Group—Focus
Group Participants.

W1 Survey Instrument .....................

3,000

1

20/60

1,000

W2 Survey Instrument .....................

1,200

1

20/60

400

Survivor Interview Guide ..................
Caregiver Survey Instrument ...........
Caregiver Interview Guide ...............
Advocacy Representatives Focus
Group Guide.

20
900
20
16

1
1
1
1

1
15/60
1
1

20
225
20
16

Total ...........................................

...........................................................

........................

........................

........................

1,681

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2023–20760 Filed 9–25–23; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
[CFDA Number: 93.568]

Proposed Reallotment of Fiscal Year
2022 Funds for the Low Income Home
Energy Assistance Program
Office of Community Services,
Administration for Children and
Families, Department of Health and
Human Services.
ACTION: Notice of public comment.
AGENCY:

The Administration for
Children and Families (ACF), Office of
Community Service (OCS), Division of
Energy Assistance announces a
preliminary determination that funds
from the Federal fiscal year (FFY) 2022
Low Income Home Energy Assistance
Program (LIHEAP) are available for
reallotment to States, Territories, Tribes,
and Tribal organizations that received
FFY 2023 direct LIHEAP grants. The
purpose of this award is to redistribute
FFY 2022 annual LIHEAP funds that
grant recipients were unable to obligate
or carry over to FFY 2023. No subrecipients of these grant recipients or
other entities may apply for these funds.

SUMMARY:

lotter on DSK11XQN23PROD with NOTICES1

Number of
responses per
respondent

Number of
respondents

Type of respondents

VerDate Sep<11>2014

18:18 Sep 25, 2023

Jkt 259001

Comments are due by: October
26, 2023.
ADDRESSES: Comments may be
submitted to: Peter Edelman, Program
Analyst, Office of Community Services,
Administration for Children and
Families, 330 C Street SW, 5th Floor;
Mail Room 5425; Washington, DC 20201
or via email: peter.edelman@
acf.hhs.gov. Comments may also be
faxed to 202–401–5661.
FOR FURTHER INFORMATION CONTACT:
Akm Rahman, Program Operations
Branch Chief, Division of Energy
Assistance, Office of Community
Services, 330 C Street SW, 5th Floor;
Mail Room 5425; Washington, DC,
20201. Telephone: 202–401–5306;
email: [email protected].
SUPPLEMENTARY INFORMATION: After
receiving Federal Financial Reports
(FFRs) and Carryover and Reallotment
Reports (CRRs) from FFY 2022 LIHEAP
recipients, ACF has determined that
$21,985,238 in FFY 2022 LIHEAP funds
were available for reallotment for FFY
2023. This determination was based on
the reports of 73 recipients, the total
obligations of 3 recipients, and minor
corrections to certain amounts available
for carryover. LIHEAP recipients
submitted the FFY 2022 CRRs to OCS,
as required by regulations applicable to
LIHEAP at 45 CFR 96.81(b).
The LIHEAP statute allows grant
recipients who have funds unobligated
at the end of the FFY for which they are
awarded to request that they be allowed
to carry over up to 10 percent of their
full-year allotments to the next FFY (42
U.S.C. 8626(b)(2)). Funds in excess of
this amount must be returned to the
U.S. Department of Health and Human
DATES:

PO 00000

Frm 00060

Fmt 4703

Sfmt 4703

Services and are subject to reallotment
under 42 U.S.C. 8626(b)(1).
FFY 2022 funds appropriated under
the American Rescue Plan Act of 2022
(Pub. L. 117–2) were not subject to 42
U.S.C. 8626(b)(2)(B), which caps
carryover at 10 percent. Therefore, these
funds were not included in the
reallotment calculation.
In accordance with 42 U.S.C.
8626(b)(3), ACF notified each of the 76
recipients that reported or, in the
absence of reporting, had potentially
$21,985,238 of unobligated funds above
their carryover caps. In these notices,
ACF told each about the amount it
returned for de-obligation and the
amount that will be redistributed to FFY
2023 grant recipients as part of the
reallotment. It also gave each recipient
30 calendar days to provide comments
directly to ACF.
If funds are reallotted, then they will
be allocated in accordance with 42
U.S.C. 8623 and must be treated by
LIHEAP grant recipients that receive
them as an amount appropriated for
FFY 2023. As FFY 2023 funds, they will
be subject to all requirements of the
LIHEAP statute, including 42 U.S.C.
8626(b)(2), which requires that a grantee
obligate at least 90 percent of its total
block grant allocation for a fiscal year by
the end of the fiscal year for which the
funds are appropriated; that is, by
September 30, 2023.
All LIHEAP grant recipients that
receive a portion of these funds will be
notified of the final reallotment amount
redistributed to them for obligation in
FFY 2023. This decision will also be
published in the Federal Register and in
a Dear Colleague Letter that is posted to

E:\FR\FM\26SEN1.SGM

26SEN1